Inflammatory Bowel Disease (IBD) is a chronic condition that affects approximately 3 million people in the U.S. alone. Comprising two conditions (Crohn’s disease and ulcerative colitis), IBD is characterized by chronic inflammation of the gastrointestinal (GI) tract with periods of remission and relapse.
To help address the myriad challenges faced by IBD patients and their caregivers, the Competitor is pleased to announce the Innovation Challenge: Transforming IBD Care to help identify innovative new ideas and solutions for patients living with this condition (“the Challenge”). The goal of the Challenge is to identify innovative ideas and potential solutions for better disease monitoring, management, and care for people with Inflammatory Bowel Disease. Sample topics include disease monitoring, condition management, clinical decision support, and care enhancement.
The Lilly Transforming IBD Care Challenge is a call for novel solutions for IBD patients, caregivers, and clinicians. What cutting edge technologies and systems — mobile apps, sensors and wearables, connected drug delivery devices, real-time monitoring systems, algorithms, digital games, etc. — can be deployed to enhance care and improve health and wellbeing of patients with IBD?
Submissions to this Challenge must be received by 6:59 a.m. EEST Oct. 1, 2019.